CASI Pharmaceuticals (NASDAQ:CASI) Downgraded by BidaskClub

Retrieved on: 2018-02-25 02:00:00

Tags for this article:

Click the tags to see associated articles and topics

CASI Pharmaceuticals (NASDAQ:CASI) Downgraded by BidaskClub. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC grew its position in CASI Pharmaceuticals by 33.4% in the 4th quarter. <b>Renaissance Technologies</b> LLC now owns 150,600 shares of the biotechnology company's stock worth $489,000 after purchasing an additional 37,700 shares during the last quarter. Millennium ...</div>

Article found on:

View Original Article